AP NEWS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit

March 26, 2019

NASHUA, N.H., March 26, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief Executive Officer, and Stacey Stevens, Chief Strategy & Commercial Officer, will be present a corporate overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit, being held March 27 in New York City.

Presentation Details: Date: Wednesday, March 27 Time: 2:00pm Eastern Time

About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:

Investor Relations:LifeSci AdvisorsJeremy Feffer(212) 915-2568 jeremy@lifesciadvisors.com

or:

Media Inquiries:ARPR, on behalf of iCAD, Inc.Paul Barren(855) 300-8209 paul@arpr.com